Veeva Systems Inc. VEEV is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The ...

Institutional support and a healthy fundamental backdrop make this company worth investigating. As you can see, VEEV has had strong sales and earnings growth: Also, EPS is estimated to ramp higher ...

We came across a bullish thesis on Veeva Systems Inc. (VEEV) on Substack by Francesco Ferrari. In this article, we will ...

Two years after first announcing the partnership, Boehringer Ingelheim and software firm Veeva Systems have launched ...

Boehringer Ingelheim and Veeva Systems (NYSE: VEEV) have announced the launch of Boehringer's One Medicine Platform, powered ...

Shares of Veeva Systems (NYSE: VEEV) are posting big gains in Thursday's trading despite broader sell-offs for the tech ...

Veeva released Q4 result on March 5 th, reporting 14.3% revenue growth and 28.7% adj. operating profit growth, as detailed in ...

Veeva Systems (NYSE:VEEV – Free Report) had its target price boosted by Morgan Stanley from $195.00 to $201.00 in a report ...

EST Veeva (VEEV) reports Q4 subscription services revenues of $608.6M, up 17% y/yDiscover the Best Stocks and Maximize Your Portfolio: ...

Veeva Systems Inc. (NYSE:VEEV – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the twenty-five ...

Subscription services revenue rose to $608.6 million, marking a 16.7% year-over-year growth. Veeva Systems exceeded earnings expectations for Q4 2025, while demonstrating solid revenue growth and ...

Boehringer Ingelheim and Veeva Systems have announced the launch of Boehringer’s One Medicine Platform, powered by the successful implementation of Veeva Development Cloud. They ...